{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:22:13Z","timestamp":1785435733763,"version":"3.56.0"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/06099-8, 2018\/13895-0, and 2015\/17117-8"],"award-info":[{"award-number":["2022\/06099-8, 2018\/13895-0, and 2015\/17117-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2022\/06099-8, 2018\/13895-0, and 2015\/17117-8"],"award-info":[{"award-number":["2022\/06099-8, 2018\/13895-0, and 2015\/17117-8"]}],"id":[{"id":"https:\/\/ror.org\/02ddkpn78","id-type":"ROR","asserted-by":"publisher"}]},{"name":"FAPESP Postdoctoral Fellowship","award":["2017\/17006-2"],"award-info":[{"award-number":["2017\/17006-2"]}]},{"name":"FAPESP Research Internship Abroad (BEPE) Fellowship","award":["2015\/07153-2"],"award-info":[{"award-number":["2015\/07153-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Hemolytic Uremic Syndrome (HUS) is a severe clinical manifestation primarily triggered by Shiga toxin-producing Escherichia coli (STEC). While Shiga toxins (Stx) are central to the development of systemic endothelial damage, current recombinant antibody developments have overwhelmingly focused on neutralizing the Stx2 subtype. However, numerous STEC isolates produce Stx1 either independently or alongside Stx2, revealing a critical need to diversify the antibody repertoire for comprehensive antitoxin therapies. To address this, we characterized two novel, fully human recombinant Fabs targeting Stx1 (FabB6:Stx1 and FabC8:Stx1) selected from a synthetic library via phage display. We evaluated their binding specificity and neutralizing activity in Vero and human proximal tubular epithelial (HK-2) cells, as well as in primary human glomerular endothelial cells (HGEC exposed to HUS-derived STEC supernatants. Both Fabs exhibited high specificity and nanomolar affinity for Stx1. Notably, they displayed cell-type-dependent neutralization profiles, with FabC8:Stx1 demonstrating superior and more consistent neutralization in HK-2 cells. Crucially, when evaluated alongside previously characterized anti-Stx2 antibodies (FabC11:Stx1\/Stx2 and FabF8:Stx2), the Stx1-specific Fabs conferred complementary protection against clinical STEC isolates. These findings support the inclusion of Stx1-targeting recombinant antibodies into broader multi-toxin neutralization strategies, thereby expanding the therapeutic potential against STEC-associated diseases.<\/jats:p>","DOI":"10.3390\/toxins18060257","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:10:42Z","timestamp":1780668642000},"page":"257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant Human Fab Antibodies Differentially Neutralize Shiga Toxin in Renal Epithelial and Endothelial Cells"],"prefix":"10.3390","volume":"18","author":[{"given":"Fernando D.","family":"G\u00f3mez","sequence":"first","affiliation":[{"name":"Universidad de Buenos Aires, Facultad de Ciencias M\u00e9dicas, Departamento de Ciencias Fisiol\u00f3gicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121 ABG, Argentina"},{"name":"CONICET-Universidad de Buenos Aires, Instituto de Fisiolog\u00eda y Biof\u00edsica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121 ABG, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Luz","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"},{"name":"Centro de Desenvolvimento de Anticorpos, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Chinen","sequence":"additional","affiliation":[{"name":"Infectious Hazard Management Unit, Public Health Department, Pan American Health Organization, Washington DC 20037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1009-314X","authenticated-orcid":false,"given":"Daniel","family":"Gir\u00f3n","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires, Facultad de Ciencias M\u00e9dicas, Departamento de Ciencias Fisiol\u00f3gicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121 ABG, Argentina"},{"name":"CONICET-Universidad de Buenos Aires, Instituto de Fisiolog\u00eda y Biof\u00edsica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121 ABG, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raissa L.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-2850","authenticated-orcid":false,"given":"Camila","family":"Henrique","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela O. P.","family":"Bom","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"},{"name":"Centro de Desenvolvimento de Anticorpos, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella M.","family":"Henrique","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderson","family":"Marques da Silva","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires, Facultad de Ciencias M\u00e9dicas, Departamento de Ciencias Fisiol\u00f3gicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121 ABG, Argentina"},{"name":"CONICET-Universidad de Buenos Aires, Instituto de Fisiolog\u00eda y Biof\u00edsica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121 ABG, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Sacerdoti","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires, Facultad de Ciencias M\u00e9dicas, Departamento de Ciencias Fisiol\u00f3gicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121 ABG, Argentina"},{"name":"CONICET-Universidad de Buenos Aires, Instituto de Fisiolog\u00eda y Biof\u00edsica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121 ABG, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3198-4175","authenticated-orcid":false,"given":"Elizabeth S.","family":"Miliwebsky","sequence":"additional","affiliation":[{"name":"Servicio Fisiopatogenia, Departamento Bacteriolog\u00eda, Instituto Nacional de Enfermedades Infecciosas ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires C1282 AFF, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 2Z9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-4555","authenticated-orcid":false,"given":"Claudia C.","family":"Carbonari","sequence":"additional","affiliation":[{"name":"Servicio Fisiopatogenia, Departamento Bacteriolog\u00eda, Instituto Nacional de Enfermedades Infecciosas ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires C1282 AFF, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachdev S.","family":"Sidhu","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 2Z9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-8506","authenticated-orcid":false,"given":"Roxane M. F.","family":"Piazza","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Bacteriologia, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"},{"name":"Centro de Desenvolvimento de Anticorpos, Instituto Butantan, S\u00e3o Paulo, SP 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Marta","family":"Amaral","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires, Facultad de Ciencias M\u00e9dicas, Departamento de Ciencias Fisiol\u00f3gicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121 ABG, Argentina"},{"name":"CONICET-Universidad de Buenos Aires, Instituto de Fisiolog\u00eda y Biof\u00edsica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121 ABG, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/ki.1997.508","article-title":"Epidemic hemolytic-uremic syndrome in children","volume":"52","author":"Repetto","year":"1997","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00467-018-3991-6","article-title":"Hyponatremia: A new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome","volume":"33","author":"Alconcher","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_3","first-page":"573","article-title":"Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis","volume":"2","author":"LaVeck","year":"1983","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/iai.61.8.3392-3402.1993","article-title":"Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice","volume":"61","author":"Tesh","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_5","first-page":"341","article-title":"New therapeutic developments against Shiga toxin-producing Escherichia coli","volume":"2","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2019.05.018","article-title":"Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: A global overview","volume":"79","author":"Kakoullis","year":"2019","journal-title":"J. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcl.2018.09.011","article-title":"Hemolytic uremic syndrome","volume":"66","author":"Cody","year":"2019","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"M\u00fchlen, S., and Dersch, P. (2020). Treatment strategies for infections with Shiga toxin-producing Escherichia coli. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00169"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Henrique, I.M., Sacerdoti, F., Ferreira, R.L., Henrique, C., Amaral, M.M., Piazza, R.M.F., and Luz, D. (2022). Therapeutic antibodies against Shiga toxins: Trends and perspectives. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.825856"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00467-025-06704-6","article-title":"Role of INM004 Shiga-toxin antibodies in treatment of STEC-HUS","volume":"40","author":"Andreoli","year":"2025","journal-title":"Pediatr. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rivas, M., Pichel, M., Zylberman, V., Colonna, M., Valerio, M., Massa, C., Pardo, R., Ciocchini, A.E., Sanguineti, S., and Roubicek, I. (2025). INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome. Toxins, 17.","DOI":"10.3390\/toxins17060282"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Luz, D., Chen, G., Maranh\u00e3o, A.Q., Rocha, L.B., Sidhu, S., and Piazza, R.M. (2015). Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120481"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Luz, D., Amaral, M.M., Sacerdoti, F., Bernal, A.M., Quintilio, W., Moro, A.M., Palermo, M.S., Ibarra, C., and Piazza, R.M.F. (2018). Human recombinant Fab fragment neutralizes Shiga toxin type 2 cytotoxic effects in vitro and in vivo. Toxins, 10.","DOI":"10.3390\/toxins10120508"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Luz, D., G\u00f3mez, F.D., Ferreira, R.L., Melo, B.S., Guth, B.E., Quintilio, W., Moro, A.M., Presta, A., Sacerdoti, F., and Ibarra, C. (2021). The deleterious effects of Shiga toxin type 2 are neutralized in vitro by FabF8:Stx2 recombinant monoclonal antibody. Toxins, 13.","DOI":"10.3390\/toxins13110825"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/iai.50.3.695-700.1985","article-title":"Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli","volume":"50","author":"Strockbine","year":"1985","journal-title":"Infect. Immun."},{"key":"ref_16","unstructured":"Kaper, J.B., and O\u2019Brien, A.D. (1998). Vero cell neutralization and mouse protective efficacy of humanized monoclonal antibodies against Escherichia coli toxins Stx1 and Stx2. Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains, ASM Press."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1128\/AAC.01661-08","article-title":"Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers","volume":"53","author":"Bitzan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1128\/IAI.70.10.5896-5899.2002","article-title":"Production and characterization of protective human antibodies against Shiga toxin 1","volume":"70","author":"Mukherjee","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1348-0421.2002.tb02764.x","article-title":"Monoclonal antibody to Shiga toxin 1, which blocks receptor binding and neutralizes cytotoxicity","volume":"46","author":"Nakao","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tarr, G.A.M., Stokowski, T., Shringi, S., Tarr, P.I., Freedman, S., Oltean, H.N., Rabinowitz, P.M., and Chui, L. (2019). Contribution and interaction of Shiga toxin genes to Escherichia coli O157:H7 virulence. Toxins, 11.","DOI":"10.3390\/toxins11100607"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-020-04560-0","article-title":"Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: Incidence, risk factors, and clinical outcome","volume":"35","author":"Ylinen","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00467-020-04697-y","article-title":"Is Shiga toxin 1 protective for the development of Shiga toxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network","volume":"35","author":"Ardissino","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Detzner, J., Krojnewski, E., Pohlentz, G., Steil, D., Humpf, H.U., Mellmann, A., Karch, H., and M\u00fcthing, J. (2021). Shiga toxin (Stx)-binding glycosphingolipids of primary human renal cortical epithelial cells (pHRCEpiCs) and Stx-mediated cytotoxicity. Toxins, 13.","DOI":"10.3390\/toxins13020139"},{"key":"ref_24","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0966-842X(96)10017-2","article-title":"Role of verotoxin receptors in pathogenesis","volume":"4","author":"Lingwood","year":"1996","journal-title":"Trends Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/toxins2122769","article-title":"Escherichia coli Shiga toxin mechanisms of action in renal disease","volume":"2","author":"Obrig","year":"2010","journal-title":"Toxins"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Amaral, M.M., Sacerdoti, F., Jancic, C., Repetto, H.A., Paton, A.W., Paton, J.C., and Ibarra, C. (2013). Action of Shiga toxin type 2 and subtilase cytotoxin on human microvascular endothelial cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070431"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/IAI.05139-11","article-title":"Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2","volume":"79","author":"Lenz","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1038\/srep16663","article-title":"The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage","volume":"5","author":"Ogura","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_30","first-page":"mgen000935","article-title":"Alteration of a Shiga toxin-encoding phage associated with a change in toxin production level and disease severity in Escherichia coli","volume":"9","author":"Miyata","year":"2023","journal-title":"Microb. Genom."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Silva, M.A., Santos, A.R.R., Rocha, L.B., Caetano, B.A., Mitsunari, T., Santos, L.I., Polatto, J.M., Horton, D.S.P.Q., Guth, B.E.C., and Dos Santos, L.F. (2019). Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay. Microorganisms, 7.","DOI":"10.3390\/microorganisms7090276"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/35054089","article-title":"Genome sequence of enterohaemorrhagic Escherichia coli O157:H7","volume":"409","author":"Perna","year":"2001","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jmb.2012.11.037","article-title":"CDR-H3 diversity is not required for antigen recognition by synthetic antibodies","volume":"425","author":"Persson","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio843","article-title":"Synthetic therapeutic antibodies","volume":"2","author":"Sidhu","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105965","DOI":"10.1016\/j.mimet.2020.105965","article-title":"Rapid detection of Shiga toxin-producing Escherichia coli using recombinant antibodies","volume":"175","author":"Shiga","year":"2020","journal-title":"J. Microbiol. Methods"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/6\/257\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:19:59Z","timestamp":1781151599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/6\/257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["toxins18060257"],"URL":"https:\/\/doi.org\/10.3390\/toxins18060257","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}